These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 11417194
41. Triple therapy and initial renal graft perfusion. Thomsen HS, Nielsen SL. Dan Med Bull; 1988 Aug; 35(4):393-5. PubMed ID: 3048925 [Abstract] [Full Text] [Related]
42. The role of C-reactive protein in graft dysfunction after renal transplantation. Reek C, Conrad S, Huland H. J Urol; 1999 May; 161(5):1463-6. PubMed ID: 10210373 [Abstract] [Full Text] [Related]
43. [Application of urinary free dopamine as a marker of renal function, and comparison with other renal marker]. Komori T, Habuchi Y, Inoue H, Sakai T, Suzuki K, Ohtsuka K, Tanaka H, Fujita N, Yoshimura M. Rinsho Byori; 1997 Jul; 45(7):679-84. PubMed ID: 9256016 [Abstract] [Full Text] [Related]
44. Glomerular proteinuria as an early sign of renal-transplant rejection. Steinhoff J, Feddersen A, Wood WG, Hoyer J, Sack K. Clin Nephrol; 1991 Jun; 35(6):255-62. PubMed ID: 1873939 [Abstract] [Full Text] [Related]
45. Temporal changes of cytokines and nitric oxide products in urine from renal transplant patients. Smith SD, Wheeler MA, Lorber MI, Weiss RM. Kidney Int; 2000 Aug; 58(2):829-37. PubMed ID: 10916108 [Abstract] [Full Text] [Related]
46. [Kidney transplantation and tumors]. Lácha J, Jirka J, Nouza M, Chadimová M, Rossmann P. Cas Lek Cesk; 1994 Sep 26; 133(18):562-5. PubMed ID: 7954667 [Abstract] [Full Text] [Related]
47. Are serum concentrations of nitric oxide metabolites useful for predicting the clinical outcome of severe ulcerative colitis? Rees DC, Satsangi J, Cornelissen PL, Travis SP, White J, Jewell DP. Eur J Gastroenterol Hepatol; 1995 Mar 26; 7(3):227-30. PubMed ID: 7743304 [Abstract] [Full Text] [Related]
48. [Clinical relevance of N-acetylglucosaminidase determination in urine of kidney transplant recipients with and without cyclosporin A]. Loertscher R, Scholer A, Brunner F, Harder F, Thiel G. Schweiz Med Wochenschr; 1982 Nov 13; 112(46):1658-64. PubMed ID: 6760389 [Abstract] [Full Text] [Related]
49. Cyclosporin A efficacy and toxicity in organ transplantation with special focus on cadaveric renal transplantation. Lesne M, Squifflet JP, Wallemacq P, Lenain F, Alexandre G. Chemioterapia; 1985 Oct 13; 4(5):400-5. PubMed ID: 3907864 [Abstract] [Full Text] [Related]
50. Cadaveric renal transplantation in patients over 55 years of age with special emphasis on immunosuppressive therapy. Lundgren G, Fehrman I, Gunnarsson R, Lindholm B, Tillegård A, Ost L, Groth CG. Transplant Proc; 1982 Sep 13; 14(3):601-4. PubMed ID: 6758244 [No Abstract] [Full Text] [Related]
51. The use of cyclosporin A and prednisone in cadaver kidney transplantation. Starzl TE, Weil R, Iwatsuki S, Klintmalm G, Schröter GP, Koep LJ, Iwaki Y, Terasaki PI, Porter KA. Surg Gynecol Obstet; 1980 Jul 13; 151(1):17-26. PubMed ID: 6992310 [Abstract] [Full Text] [Related]
52. Evidence for increased nitric oxide production after liver transplantation in humans. Ioannidis I, Hellinger A, Dehmlow C, Rauen U, Erhard J, Eigler FW, De Groot H. Transplantation; 1995 May 15; 59(9):1293-7. PubMed ID: 7762064 [Abstract] [Full Text] [Related]
53. Renal transplantation for chronic renal failure in acute porphyria. Nunez DJ, Williams PF, Herrick AL, Evans DB, McColl KE. Nephrol Dial Transplant; 1987 May 15; 2(4):271-4. PubMed ID: 3118271 [Abstract] [Full Text] [Related]
54. Serum, urinary, and salivary nitric oxide in rheumatoid arthritis: complexities of interpreting nitric oxide measures. Weinberg JB, Lang T, Wilkinson WE, Pisetsky DS, St Clair EW. Arthritis Res Ther; 2006 May 15; 8(5):R140. PubMed ID: 16907988 [Abstract] [Full Text] [Related]
55. Limits of clinical signs and non-invasive techniques in detecting severe acute rejection. Bertoni E, Di Maria L, Piperno R, Zanazzi M, Rosati A, Moscarelli L, Salvadori M. J Nephrol; 1999 May 15; 12(2):100-3. PubMed ID: 10378666 [Abstract] [Full Text] [Related]
56. [C-reactive protein in the urine. The differential diagnosis of renal functional disorders following kidney transplantation]. Steinhoff J, Bühner U, Feddersen A, Wood WG, Preuss R, Fricke L, Faerber P, Dodt C, Hoyer J, Sack K. Dtsch Med Wochenschr; 1992 Jun 05; 117(23):894-9. PubMed ID: 1597117 [Abstract] [Full Text] [Related]
57. [Diagnostic and prognostic value of kidney function tests in cadaveric kidney transplantation]. Potashov LV, Shabanova LN, Protasov AA, Galibin OV, Kabakov AB. Ter Arkh; 1985 Jun 05; 57(6):94-8. PubMed ID: 3906992 [Abstract] [Full Text] [Related]
58. Renography and biopsy-verified acute rejection in renal allotransplanted patients receiving cyclosporin A. Thomsen HS, Nielsen SL, Larsen S, Løkkegaard H. Eur J Nucl Med; 1987 Jun 05; 12(10):473-6. PubMed ID: 3552684 [Abstract] [Full Text] [Related]
59. [Clinical results of immunosuppression with cyclosporin A in cadaveric kidney transplantation]. Madsen S, Kristensen JK, Langhoff E, Olgaard K, Ladefoged J, Thaysen JH. Ugeskr Laeger; 1984 Mar 26; 146(13):951-4. PubMed ID: 6372185 [No Abstract] [Full Text] [Related]
60. Targeted blood levels of cyclosporin for cardiac transplantation. Griffith BP, Hardesty RL, Trento A, Lee A, Bahnson HT. J Thorac Cardiovasc Surg; 1984 Dec 26; 88(6):952-7. PubMed ID: 6389991 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]